We have located links that may give you full text access.
Ocular hypotensive actions of haloperidol, a dopaminergic antagonist.
Archives of Ophthalmology 1984 January
Haloperidol, a dopaminergic antagonist, was found to be very effective in suppressing the intraocular pressure recovery curve of rabbits infused with 20% saline intravenously. Haloperidol was at least equipotent, if not more potent, in lowering IOP and had much longer duration of action compared with timolol maleate. In the cat model, haloperidol increased aqueous humor (AH) outflow initially, followed by a long-lasting suppression of AH formation. Since haloperidol does not block beta-adrenergic receptors and the ophthalmic dose required to lower IOP is only 6.5% of the antipsychotic dose, haloperidol might be a good drug for glaucoma treatment with the possibility of minimal side effects.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app